A watershed moment for the BJD: Authors retain their article copyright 'I don't own one word of this. Even though I spent hours writing it and was not paid. If you don't believe me, look at the copyright statement at the bottom of this page.' 1 So wrote Professor Andrew Finlay in a BJD Editorial on copyright in 2015. At the time he was entirely right that, except for articles published as open access, authors publishing their work in most medical journals assigned copyright to the journal's owner. While in most cases there are few practical consequences, this copyright transfer can make a big difference, an example being papers which describe a novel outcome measure instrument subsequently used in multiple commercial clinical trials where a fee for use is charged. Is every medical publisher the same on this issue? All will be revealed later…! From 1 st January 2023, following a competitive bid process, The British Association of Dermatologists changed its publisher for BJD and our companion journal, Clinical and Experimental Dermatology, from Wiley to Oxford University Press (OUP). Watershed moments like this provide an opportunity to reflect on progress and look ahead to future journal enhancements. The COVID pandemic has certainly allowed dermatology publishing to have greater impact on medicine and society as a whole than it had previously. The BJD was fortunate to publish several high-quality COVID submissions, including papers covering classification of rashes from COVID infection, 2 efforts to visualize SARS-CoV-2 proteins in the endothelial cells of acral chilblains, 3 and skin reaction patterns from COVID vaccination. 4 The COVID Symptom Study app paper in the